Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
14,22 USD | -1,25 % | +2,89 % | -5,20 % |
Resumen de negocios
Número de empleados: 200
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
RTGel Reverse-Thermal Hydrogel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 62 | 03/01/19 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 01/08/21 |
Jason Smith
CMP | Compliance Officer | 52 | 09/09/20 |
Marina Konorty
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/11 |
Moran Mieron
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mark Schoenberg
CTO | Chief Tech/Sci/R&D Officer | 66 | 09/02/16 |
Investor Relations Contact | - | 01/01/22 | |
Polly Murphy
PRN | Corporate Officer/Principal | 59 | 09/09/20 |
Jeff Bova
PRN | Corporate Officer/Principal | - | 01/01/17 |
James Ottinger
LAW | General Counsel | - | 01/10/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 01/10/12 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 01/10/17 |
Fred Cohen
BRD | Director/Board Member | 67 | 16/05/17 |
Stuart Holden
BRD | Director/Board Member | 82 | 01/12/15 |
Chief Executive Officer | 62 | 03/01/19 | |
James Robinson
BRD | Director/Board Member | 54 | 25/07/23 |
Daniel Wildman
BRD | Director/Board Member | 68 | 08/11/22 |
Leana Wen
BRD | Director/Board Member | 41 | 12/09/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 36 130 121 | 32 257 075 ( 89,28 %) | 0 | 89,28 % |
Información de la empresa
UroGen Pharma Ltd.
400 Alexander Park Drive 4th floor
08540, Princeton
+(646) 768-9780
http://www.urogen.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-5,20 % | 487 M | |
-1,65 % | 103 mil M | |
+6,75 % | 101 mil M | |
+5,71 % | 23,07 mil M | |
-12,60 % | 22,23 mil M | |
-9,70 % | 18,05 mil M | |
-39,98 % | 17,18 mil M | |
-10,17 % | 16,94 mil M | |
+6,12 % | 14,07 mil M | |
+35,47 % | 12,35 mil M |
- Bolsa de valores
- Acciones
- Acción URGN
- Empresa UroGen Pharma Ltd.